Loading
Life sciences · Observational Study
ClinicalTrials.gov · November 6, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Observational Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07921719). This is a study registration, not published results. Lead sponsor: Hospices Civils de Lyon. Recruitment status: NOT_YET_RECRUITING. Study type: OBSERVATIONAL. Enrollment: 5400 participants (ESTIMATED). Conditions: Smoking Cessation, Lung Cancer Screening. Interventions: OTHER: PROMETHEE Cohort; OTHER: Control Cohort. Primary outcome measures: Self-reported Smoking Cessation at 12 Months , 12 months. Brief summary: This prospective observational study aims to evaluate whether an intensive tele-tobacco cessation program delivered through the PROMETHEE platform improves smoking cessation among smokers participating in the French national lung cancer screening pilot program IMPULSION. Participants receiving the PROMETHEE pathway will be compared with matched controls receiving standard smoking cessation support available through IMPULSION. The primary endpoint is self-reported smoking cessation at 12 months.